hVIVO contract the fruit of increasing Asian focus

ADVERTISEMENT

Click to copy

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

Click to copy

Related topics

hVIVO contract the fruit of increasing Asian focus

PRESS RELEASE: Paid content from News Direct Corporation

Press release content from News Direct Corporation. The AP news staff was not involved in its creation.

January 4, 2023 GMT

None

None

--News Direct--

hVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Proactive after announcing the signing of a £5.2mln contract with a biotech company in the Asia Pacific region to test the latter’s respiratory syncytial virus (RSV) vaccine candidate. Khan says that the deal is the first hVIVO has signed in Asia in a decade, and is the result of the research company’s increasing focus on growing its sales in the region

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View original content to download multimedia: https://newsdirect.com/news/hvivo-contract-the-fruit-of-increasing-asian-focus-358578173